Formosa Laboratories is a globally-recognized generic API supplier with particular specialty in UV-filters and vitamin D derivatives. Our state-of-the-art facilities are fully GMP-compliant and have been approved by major regulatory authorities worldwide, including EMEA, USFDA, PMDA, and COFEPRIS. Formosa’s most recent developments features a comprehensive range of ADC services, including antibody manufacturing, linker/toxin CMC development, bioconjugation, and fill-finish capabilities. Contact us to learn how Formosa and its strategic partners can help achieve your goals. www.formosalab.com
FUJIFILM Diosynth Biotechnologies is an industry leading Biologics Contract Development and Manufacturing Organization with locations in Research Triangle Park, North Carolina, Billingham, United Kingdom and in College Station, Texas. FUJIFILM Diosynth Biotechnologies offers a comprehensive list of services from cell line development, including its proprietary pAVEway™ microbial and Apollo™ mammalian… Read More.
Genovis provides unique enzymes suitable for development and characterization of ADCs, mAbs, proteins, Fc-fusion proteins and biosimilars. The SmartEnzymes™ portfolio consists of:
- FabRICATOR® (IdeS), FabRICATOR®Z (IdeZ), FabULOUS® (SpeB) and GingisKHAN™ (Kgp). These enzymes are for preparation of subunits for further analysis using LC and MS.
- IgGZERO® (EndoS) and GlycINAT… Read More.
MaxCyte’s non-viral delivery platform allows for engineering of nearly all cell types, including human primary cells, with any molecule, at any scale for use in drug discovery and development, biomanufacturing, gene editing, cell therapy, and immuno-oncology. Its consistency and minimal cell disturbance facilitate rapid, clinical and commercial grade cell engineering.
MicroBiopharm Japan has been manufacturing highly potent compounds by its unique fermentation technology for a long time. These highly potent compounds and their derivatives are used as anticancer drugs usually. In addition, these highly potent compounds could also be used as payloads in the field of ADC such as DM-1 (Ansamitocin P3 derivative), Doxorubicin, Alpha-amanitin, Camptotecin analogues, and so on. MBJ supports customer’s development of ADC drugs by supply these payloads and their linker conjugates with flexibility in compliance to required specification.
Mitra Biotech is a global leader in advancing personalized cancer treatment and empowering drug development & discovery.
Our phenotypic CANscript platform delivers powerful insight for our biopharma partners. Because CANscript conserves the native tumor microenvironment and delivers 1:1 clinical correlation… Read More
NOF Corporation is the leading commercial supplier of activated PEG products and is providing site-specific linkers, such as, linear and branched hetero-activated PEG, and single molecular weight PEGs for the development of next generation Antibody-Drug Conjugates. NOF also supplies ultra-pure polysorbates 20 and 80 for stabilizing the formulation of antibody and protein… Read More.
Pierre FABRE CDMO proposes its international partners a full service, from clinical development to commercial production in the following fields of expertises: manufacturing of APIs, supercritical CO2 formulation, production of pharmaceutical lozenges and fill & finish of injectable products (vials, prefilled syringes), including conventional cytotoxic and biotechnology products… Read More.
Formed in 2016, PROVEO™ is a four-company CMO alliance providing seamless, end-to-end solutions for the process development and cGMP manufacture of ADCs. Combining integrated project management, logistics, supply chain, and production—the PROVEO Alliance blends decades of industry experience and competencies with proven capabilities and the very latest in technological innovation to deliver an unmatched quality, dependability, and… Read More.